Sorry, you need to enable JavaScript to visit this website.

Nestlé Waters North America Statement March 11, 2008 - Pharmaceuticals Drinking Water

Go back to Press Releases
Mar 10, 2008

Nestlé Waters North America employs a multiple barrier process of quality for all of its bottled water products. These barriers work together to protect the safety of the water.

For our Purified Waters: For our purified waters that use public supplies, like Nestlé® Pure Life®, we employ two highly effective barriers for removing pharmaceuticals and hormones. These are Granular Activated Carbon filtration and Reverse Osmosis filtration. These are specialized water treatment processes which are not typically used in municipal treatment operations.

For our Spring Waters: Our spring sources are carefully selected to protect against the potential of chemical, bacteriological and surface water contamination, which reassures us that contaminants associated with human activity such as pharmaceuticals or hormones are either absent or below detectable limits.

We study the composition of the water as well as the watershed area. We often purchase large tracts of land around our springs and leave them undeveloped, which helps protect the source water.

Spring water is typically treated with ozone disinfection, which is also considered an effective barrier for many pharmaceuticals.

Following these steps for both spring and purified water types, the water is then hygienically bottled in an enclosed, sanitary bottling room. All bottled water sources and finished products are tested on a daily, weekly and annual basis, following U.S. Food & Drug Administration guidelines for good manufacturing practices. Each label carries a 1-800 number so consumers can contact the company should there be any concerns.

Based on all the data and monitoring in our process, we are confident that there are no risks from pharmaceutical compounds and hormones in our finished products. We continue to look at emerging issues, and will be testing our products for specific classes of pharmaceutical compounds to provide further assurances.

Article Type